Search
for
Sort by
Research 331–360 of 1000+
- Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain
- Androgens and Hirsutism in a Large Cohort of Portuguese Women
- Approach to the Patient: Diagnostic Challenges in the Work Up for Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome and Eating Disorders—A Literature Review
- The Impact of Vitamin D Receptor Gene Polymorphisms (FokI, ApaI, TaqI) in Correlation with Oxidative Stress and Hormonal and Dermatologic Manifestations in Polycystic Ovary Syndrome
- Body Fat Distribution in Thai Reproductive-Aged Polycystic Ovary Syndrome Women Compared with Non-Polycystic Ovary Syndrome Women
- Myo-Inositol (ProFecund Ino) – Obtaining a Pregnancy in Women with Polycystic Ovary Syndrome
- Relationship between Serum 25-Hydroxyvitamin D Levels and Hormonal Status in Infertile Women: A Retrospective Study
- Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
- Differences in Demographic and Clinical Characteristics Among Subtypes of Female Pattern Hair Loss
- How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?
- Study of women's knowledge of the role of androgens and their excess in women - research article
- Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature
- Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
- Prevalence of Cutaneous Disorders in Patients with Polycystic Ovary Syndrome
- Diagnostic Criteria for PCOS
- Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis
- Treatment of hirsutism and acne in hyperandrogenism
- Cutaneous manifestations of polycystic ovary syndrome: A cross-sectional clinical study
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- Pre‐polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set
- A systematic review of models of care for polycystic ovary syndrome highlights the gap in the literature, especially in developing countries
- Optical Coherence Tomography Angiography Findings in Polycystic Ovary Syndrome
- A narrative review on cutaneous manifestations in polycystic ovary syndrome: pathophysiology, diagnosis, management, and psychosocial impact
- Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes
- A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?
- Treatment options for polycystic ovary syndrome
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population